PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Camptothecin is a potent anti-tumor drug with clinically proven properties against various human malignancies [PMID:34850279, PMID:32976723, PMID:26949094]
Virtual screening and molecular docking suggest that 4,4,5,8-tetramethyl-2,3-dihydrochromen-2-ol from N. nimmoniana may bind to TNF-α and hER-α, potentially aiding in PCOS management [PMID:40971244]
Evidence summary
PubMed sources
- 1.PMID: 37516285 (2023) — Chloroplast genome sequence of Nothapodytes nimmoniana (Icacinaceae), a vulnerable reservoir of camptothecin from Western Ghats. · Gene
- 2.PMID: 40628740 (2025) — Chromosome-level genome assembly of Nothapodytes nimmoniana. · Scientific data
- 3.PMID: 38896329 (2024) — Biotechnological approaches for the production of camptothecin. · Applied microbiology and biotechnology
- 4.PMID: 38351290 (2024) — Optimisation of enzyme-assisted extraction of camptothecin from Nothapodytes nimmoniana and its characterisation. · Phytochemical analysis : PCA
- 5.PMID: 34850279 (2021) — Biotechnology of camptothecin production in Nothapodytes nimmoniana, Ophiorrhiza sp. and Camptotheca acuminata.